The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).

LARGE SPONTANEOUS PORTOSYSTEMIC SHUNTS (SPSSs) IN PATIENTS WITH LIVER CIRRHOSIS. CLINICAL AND RADIOLOGICAL CHARACTERISTICS.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02692430

Enrollment

1000

Registered

2016-02-26

Start date

2016-04-30

Completion date

2017-12-31

Last updated

2017-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Encephalopathy, Liver Cirrhosis, Portal Hypertension

Keywords

Portosystemic Shunt, Hepatic encephalopathy, Portal hypertension, Liver cirrhosis

Brief summary

The purpose of this study is to perform a multicentre registry of cirrhotic patients who had been submitted to an imagining technique in recent years (angio-CT scan or abdominal MRI), in order to collect anatomical and clinical information. The main objective will be focused on the study of portosystemic shunts and their relation with portal hypertension. Patient with liver cirrhosis submitted to an abdominal angio-CT scan or a MRI from year 2010 to 2014 will be included in the study. The chosen imaging technique will be angio-CT preferably, but MRI data will also be available. Patients will be identified in every hospital by means of the registry of coded diagnoses and the lists of complementary tests performed. Clinical and radiological data of every patient will be collected. The clinical variables will be obtained from reviewing the patient clinical history. The radiological parameters will be gathered by means of the systematic review of the angio-CT or MRI.

Interventions

OTHERNo intervention is studied

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Liver cirrhosis * An evaluable imaging test (angio-CT or MRI) performed by any reason in the study period (from January 2010 to December 2014)

Exclusion criteria

* Presence of previous surgical shunts * Prior liver transplant * Neurological or psychiatric disorder that do not permit to establish the diagnosis of hepatic encephalopathy * Presence of hepatocellular carcinoma beyond Milan criteria * Terminal disease

Design outcomes

Primary

Measure	Time frame
Number of cirrhotic patients with a portosystemic shunt detected by angio-CT scan or MRI	4 years
Number of cirrhotic patients that develop hepatic encephalopathy as a decompensation	4 years

Secondary

Measure	Time frame
Type of portosystemic shunts detected by angio-CT scan or MRI	4 years
Number of cirrhotic patients that develop a decompensation (ascites, variceal bleeding, spontaneous bacterial peritonitis, hepatorenal syndrome)	4 years

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026